11-119108022-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001290474.2(C2CD2L):āc.281C>Gā(p.Ala94Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000394 in 1,599,168 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001290474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD2L | ENST00000648610.2 | c.281C>G | p.Ala94Gly | missense_variant | 1/14 | NM_001290474.2 | ENSP00000497391.1 | |||
C2CD2L | ENST00000336702.7 | c.281C>G | p.Ala94Gly | missense_variant | 1/14 | 1 | ENSP00000338885.3 | |||
DPAGT1 | ENST00000409993.6 | c.-1243G>C | 5_prime_UTR_variant | 1/11 | 2 | ENSP00000386597.2 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152006Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000406 AC: 9AN: 221684Hom.: 0 AF XY: 0.0000488 AC XY: 6AN XY: 123012
GnomAD4 exome AF: 0.0000200 AC: 29AN: 1447162Hom.: 0 Cov.: 32 AF XY: 0.0000208 AC XY: 15AN XY: 720264
GnomAD4 genome AF: 0.000224 AC: 34AN: 152006Hom.: 0 Cov.: 30 AF XY: 0.000229 AC XY: 17AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 04, 2024 | The c.281C>G (p.A94G) alteration is located in exon 1 (coding exon 1) of the C2CD2L gene. This alteration results from a C to G substitution at nucleotide position 281, causing the alanine (A) at amino acid position 94 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at